Clinical Trial Update: Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating PALI-2108 in healthy volunteers and ulcerative colitis patients has completed, with focus on safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PALI-2108

Snippet

Sponsor: Palisade Bio | Conditions: Ulcerative Colitis (UC), Healthy Volunteer | Phase 1 | Status: COMPLETED